|
Per the report received from czech republic, edwards received notification of a pascal precision ace procedure in tricuspid position.On post operative day (pod) 320, a single leaflet device attachment (slda) was identified.The patient, who initially presented with functional torrential tricuspid regurgitation (tr), underwent transcatheter edge to edge repair (teer) with two pascal precision ace devices in the anteroseptal (as) position on 24th april 2025.The procedure resulted in residual mild tr.On pod 320 a slda affecting the second implanted ace was detected.The patient developed recurrent severe tr with anatomical features including annular dilatation and chordal rupture.The chordal rupture had not been observed during the index procedure nor during early follow up assessments.The fcs suspects the device may have grasped chordae instead of leaflet tissue, ultimately leading to late detachment due to the fragility of this soft tissue; however, this has not been confirmed.At the time of this investigation, there is an intention to treat the patient in the future, although no reintervention has been scheduled at this moment.
|
|
The manufacturer's investigation is ongoing.A follow-up report will be submitted when the manufacturer's investigation is complete.It should be noted, the device was implanted in the tricuspid position.At this time, the pascal precision transcatheter valve repair system is only indicated for the native mitral valve in the us, addressing degenerative mitral regurgitation.But, it is approved for both tricuspid and mitral spaces in the region where the procedure was performed.Therefore, deployment in the tricuspid position will not be considered off-label in this case.
|